My Quote Request
6505-01-335-9394
20 Products
NDC00904-2465-60
ERYTHROMYCIN DELAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013359394
NSN
6505-01-335-9394
NDC00904-2465-60
ERYTHROMYCIN DELAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013359394
NSN
6505-01-335-9394
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERYTHROMYCIN DELAYED-RELEASE CAPSULES USP 250MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,PARKE DAVIX
Related Searches:
NDC00536-5225-98
TRIAMCINOLONE ACETONIDE CREAM,USP
NSN, MFG P/N
6505013353513
NSN
6505-01-335-3513
NDC00536-5225-98
TRIAMCINOLONE ACETONIDE CREAM,USP
NSN, MFG P/N
6505013353513
NSN
6505-01-335-3513
MFG
RUGBY GROUP INC
Description
ACTIVE INGREDIENT AND STRENGTH: 0.100 TRIAMCINOLONE ACETONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 454.000 GRAMS
PRIMARY CONTAINER TYPE: JAR
Related Searches:
MAOX
MAGNESIUM OXIDE TABLETS,USP
NSN, MFG P/N
6505013357401
NSN
6505-01-335-7401
MFG
MANNE KENNETH A CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 420.000 MILLIGRAMS MAGNESIUM OXIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC10706-0837-01
MAGNESIUM OXIDE TABLETS,USP
NSN, MFG P/N
6505013357401
NSN
6505-01-335-7401
NDC10706-0837-01
MAGNESIUM OXIDE TABLETS,USP
NSN, MFG P/N
6505013357401
NSN
6505-01-335-7401
MFG
MANNE KENNETH A CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 420.000 MILLIGRAMS MAGNESIUM OXIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
RENASOL
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013357402
NSN
6505-01-335-7402
RENASOL
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013357402
NSN
6505-01-335-7402
MFG
MINNTECH CORPORATION DBA RENAL SYSTEMS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 139.000 MILLIEQUIVALENTS SODIUM PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM PER LITER AND 2.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 106.500 MILLIEQUIVALENTS CHLORIDE PER LITER AND 200.000 MILLIGRAMS
ADMINISTRATION: KIDNEY IRRIGATION
PRIMARY CONTAINER CONTENT QUANTITY: 55.000 GALLONS
PRIMARY CONTAINER TYPE: DRUM
~1: DEXTROSE PER LITER AND 35.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 4.000 MILLIEQUIVALENTS ACETATE PER LITER
Related Searches:
SB-1003
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013357402
NSN
6505-01-335-7402
SB-1003
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013357402
NSN
6505-01-335-7402
MFG
MINNTECH CORPORATION DBA RENAL SYSTEMS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 139.000 MILLIEQUIVALENTS SODIUM PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM PER LITER AND 2.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 106.500 MILLIEQUIVALENTS CHLORIDE PER LITER AND 200.000 MILLIGRAMS
ADMINISTRATION: KIDNEY IRRIGATION
PRIMARY CONTAINER CONTENT QUANTITY: 55.000 GALLONS
PRIMARY CONTAINER TYPE: DRUM
~1: DEXTROSE PER LITER AND 35.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 4.000 MILLIEQUIVALENTS ACETATE PER LITER
Related Searches:
NDC00781-1883-10
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505013359163
NSN
6505-01-335-9163
NDC00781-1883-10
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505013359163
NSN
6505-01-335-9163
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC49884-0544-10
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505013359163
NSN
6505-01-335-9163
NDC49884-0544-10
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505013359163
NSN
6505-01-335-9163
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
RANITADINE
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505013359163
NSN
6505-01-335-9163
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DURAGESIC
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359388
NSN
6505-01-335-9388
DURAGESIC
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359388
NSN
6505-01-335-9388
MFG
JANSSEN PHARMACEUTICA INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FENTANYL TRANSDERMAL SYSTEM 100MCG/HOUR 72 HOURS I.S. 5S PG
OVERALL STRENGTH IN SYSTEM: 10 MG FENTANYL ACTIVE INGREDIENT
SPECIAL FEATURES: TRANSPARENT UNIT; CLASS 2
SYSTEM SIZE: 40 SQUARE CENTIMETER
USUAL DOSE: 100 MICROGRAMS PER HOUR FOR 72 HOURS
Related Searches:
NDC50458-0036-05
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359388
NSN
6505-01-335-9388
NDC50458-0036-05
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359388
NSN
6505-01-335-9388
MFG
JANSSEN PHARMACEUTICA INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FENTANYL TRANSDERMAL SYSTEM 100MCG/HOUR 72 HOURS I.S. 5S PG
OVERALL STRENGTH IN SYSTEM: 10 MG FENTANYL ACTIVE INGREDIENT
SPECIAL FEATURES: TRANSPARENT UNIT; CLASS 2
SYSTEM SIZE: 40 SQUARE CENTIMETER
USUAL DOSE: 100 MICROGRAMS PER HOUR FOR 72 HOURS
Related Searches:
DURAGESIC
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359389
NSN
6505-01-335-9389
DURAGESIC
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359389
NSN
6505-01-335-9389
MFG
JANSSEN PHARMACEUTICA INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FENTANYL TRANSDERMAL SYSTEM 75MCG/HOUR 72 HOURS I.S. 5S PG
OVERALL STRENGTH IN SYSTEM: 7.5 MG FENTANYL ACTIVE INGREDIENT
SPECIAL FEATURES: TRANSPARENT UNIT; CONTROLLED SUBSTANCE, CLASS II
SYSTEM SIZE: 30 SQUARE CENTIMETER
USUAL DOSE: 75 MICROGRAMS PER HOUR FOR 72 HOURS
Related Searches:
NDC50458-0035-05
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359389
NSN
6505-01-335-9389
NDC50458-0035-05
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359389
NSN
6505-01-335-9389
MFG
JANSSEN PHARMACEUTICA INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FENTANYL TRANSDERMAL SYSTEM 75MCG/HOUR 72 HOURS I.S. 5S PG
OVERALL STRENGTH IN SYSTEM: 7.5 MG FENTANYL ACTIVE INGREDIENT
SPECIAL FEATURES: TRANSPARENT UNIT; CONTROLLED SUBSTANCE, CLASS II
SYSTEM SIZE: 30 SQUARE CENTIMETER
USUAL DOSE: 75 MICROGRAMS PER HOUR FOR 72 HOURS
Related Searches:
DURAGESIC
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359390
NSN
6505-01-335-9390
DURAGESIC
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359390
NSN
6505-01-335-9390
MFG
JANSSEN PHARMACEUTICA INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FENTANYL TRANSDERMAL SYSTEM 50MCG/HOUR 72 HOURS I.S. 5S PG
OVERALL STRENGTH IN SYSTEM: 5 MG FENTANYL ACTIVE INGREDIENT
SPECIAL FEATURES: TRANSPARENT UNIT
SYSTEM SIZE: 20 SQUARE CENTIMETER
USUAL DOSE: 50 MICROGRAMS PER HOUR FOR 72 HOURS
Related Searches:
NDC50458-0034-05
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359390
NSN
6505-01-335-9390
NDC50458-0034-05
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359390
NSN
6505-01-335-9390
MFG
JANSSEN PHARMACEUTICA INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FENTANYL TRANSDERMAL SYSTEM 50MCG/HOUR 72 HOURS I.S. 5S PG
OVERALL STRENGTH IN SYSTEM: 5 MG FENTANYL ACTIVE INGREDIENT
SPECIAL FEATURES: TRANSPARENT UNIT
SYSTEM SIZE: 20 SQUARE CENTIMETER
USUAL DOSE: 50 MICROGRAMS PER HOUR FOR 72 HOURS
Related Searches:
DURAGESIC
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359391
NSN
6505-01-335-9391
DURAGESIC
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359391
NSN
6505-01-335-9391
MFG
JANSSEN PHARMACEUTICA INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FENTANYL TRANSDERMAL SYSTEM 25MCG/HOUR 72 HOURS I.S. 5S PG
OVERALL STRENGTH IN SYSTEM: 2.5 MG FENTANYL ACTIVE INGREDIENT
SPECIAL FEATURES: TRANSPARENT UNIT
SYSTEM SIZE: 10 SQUARE CENTIMETER
USUAL DOSE: 25 MICROGRAMS PER HOUR FOR 72 HOURS
Related Searches:
NDC50458-0033-05
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359391
NSN
6505-01-335-9391
NDC50458-0033-05
FENTANYL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013359391
NSN
6505-01-335-9391
MFG
JANSSEN PHARMACEUTICA INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FENTANYL TRANSDERMAL SYSTEM 25MCG/HOUR 72 HOURS I.S. 5S PG
OVERALL STRENGTH IN SYSTEM: 2.5 MG FENTANYL ACTIVE INGREDIENT
SPECIAL FEATURES: TRANSPARENT UNIT
SYSTEM SIZE: 10 SQUARE CENTIMETER
USUAL DOSE: 25 MICROGRAMS PER HOUR FOR 72 HOURS
Related Searches:
A90G153
ERYTHROMYCIN DELAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013359394
NSN
6505-01-335-9394
A90G153
ERYTHROMYCIN DELAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013359394
NSN
6505-01-335-9394
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERYTHROMYCIN DELAYED-RELEASE CAPSULES USP 250MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,PARKE DAVIX
Related Searches:
NDC00071-0696-24
ERYTHROMYCIN DELAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013359394
NSN
6505-01-335-9394
NDC00071-0696-24
ERYTHROMYCIN DELAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013359394
NSN
6505-01-335-9394
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERYTHROMYCIN DELAYED-RELEASE CAPSULES USP 250MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,PARKE DAVIX
Related Searches:
NDC00074-6301-13
ERYTHROMYCIN DELAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013359394
NSN
6505-01-335-9394
NDC00074-6301-13
ERYTHROMYCIN DELAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013359394
NSN
6505-01-335-9394
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERYTHROMYCIN DELAYED-RELEASE CAPSULES USP 250MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,PARKE DAVIX